• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Aegon Ltd. New York Registry Shares (Amendment)

    12/29/23 6:43:57 AM ET
    $AEG
    Life Insurance
    Finance
    Get the next $AEG alert in real time by email
    SC 13D/A 1 d626429dsc13da.htm SC 13D/A SC 13D/A

     

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 10)*

     

     

    Aegon Ltd.

    (Name of Issuer)

    Common Shares, par value €0.12 per share

    (Title of Class of Securities)

    0076CA104

    (CUSIP Number)

    J.O. van Klinken

    General Counsel

    Aegonplein 50, 2591 TV

    The Hague, The Netherlands

    +31 610198362

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    December 8, 2023

    (Date of Event Which Requires Filing of This Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box.  ☐

     

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom copies are to be sent.

     

     

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 0076CA104    13D    Page 1 of 5 pages

     

      1    

      Names of Reporting Persons

     

      Vereniging AEGON

      2  

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Source of Funds (See Instructions)

     

      OO

      5  

      Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

      ☐

      6  

      Citizenship or Place of Organization

     

      The Netherlands

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

         7     

      Sole Voting Power

     

      315,532,860*

         8   

      Shared Voting Power

     

      0

         9   

      Sole Dispositive Power

     

      315,532,860*

       10   

      Shared Dispositive Power

     

      0

    11    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      315,532,860*

    12  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares

     

      ☐

    13  

      Percent of Class Represented by Amount in Row (11)

     

      18.0%*

    14  

      Type of Reporting Person

     

      OO

     

    *

    Does not include 381,813,800 Common Shares B held by the Reporting Person, which, when combined with the Common Shares reported herein, give the Reporting Person the power to vote 32.6% of the total voting power of the Issuer.


    CUSIP No. 0076CA104    13D    Page 2 of 5 pages

     

    EXPLANATORY NOTE

    This Amendment No. 10 (“Amendment No. 10”) to Schedule 13D amends and supplements the statement on Schedule 13D originally filed with the United States Securities and Exchange Commission (the “SEC”) on January 16, 1998 (as amended, the “Schedule 13D”), relating to the common shares, par value €0.12 per share (the “Common Shares”), of Aegon Ltd., an exempted company with liability limited by shares organized under the laws of Bermuda (f/k/a Aegon N.V., a public limited company organized in the Netherlands) (the “Issuer”). Capitalized terms used herein without definition shall have the meanings set forth in the Schedule 13D.

     

    Item 4.

    Purpose of Transaction.

    Item 4 to the Schedule 13D is hereby amended and supplemented as follows:

    Share Repurchase Agreement

    On December 8, 2023, the Reporting Person entered into a share repurchase agreement (the “Share Repurchase Agreement”) with the Issuer, pursuant to which the Reporting Person agreed to participate in the second and third tranche of the Issuer’s share buyback program (the “SBB Program”) and the Issuer agreed to repurchase a certain number of Common Shares from the Reporting Person for an aggregate consideration equal to EUR 139,500,000, which will be equally distributed over the total number of trading days during the period that begins with commencement of the second tranche of the SBB Program until the end of the SBB Program on June 28, 2024, excluding any potential acceleration. The number of Common Shares that the Issuer will repurchase from the Reporting Person will be determined based on the daily volume-weighted average price per common share on Euronext Amsterdam. The Reporting Person is entering into the Share Repurchase Agreement so that its ownership of Common Shares as a percentage of the class will remain approximately the same before and after completion of the SBB Program.

    The foregoing description of the Share Repurchase Agreement does not purport to be complete and is qualified in its entirety by the full text of such agreement, which is attached as an exhibit to this Schedule 13D and incorporated herein by reference.

    Common Shares B Repurchase

    On December 18, 2023, the Issuer repurchased 112,619,440 Common Shares B from the Reporting Person for an aggregate amount of €14,804,951.58, in order to align the aggregate voting power of the Common Shares B held by the Reporting Person to 32.64% of the total voting securities of the Issuer, as specified in the Voting Rights Agreement.


    CUSIP No. 0076CA104    13D    Page 3 of 5 pages

     

    Item 5.

    Interest in Securities of the Issuer.

    Item 5 to the Schedule 13D is hereby amended and restated in its entirety as follows:

    (a) – (b)

     

      •  

    Amount beneficially owned: 315,532,860

     

      •  

    Percent of Class: 18.0%

     

      •  

    Number of shares the Reporting Person has:

     

      •  

    Sole power to vote or direct the vote: 315,532,860

     

      •  

    Shared power to vote: 0

     

      •  

    Sole power to dispose or direct the disposition of: 315,532,860

     

      •  

    Shared power to dispose or direct the disposition of: 0

    The above percentage is based on 1,754,432,171 Common Shares outstanding as of December 18, 2023, as disclosed by the Issuer.

    The amounts reported in this Item 5 do not include the Common Shares B beneficially owned by the Reporting Person. The Reporting Person has the sole power to vote and dispose of 381,813,800 Common Shares B, which, when combined with the Common Shares reported above, give the Reporting Person the power to vote 32.6% of the total voting power of the Issuer.

     

    (c)

    During the past 60 days, the Reporting Person has not effected any transactions with respect to the Common Shares.

     

    (d)

    None.

     

    (e)

    Not applicable.


    CUSIP No. 0076CA104    13D    Page 4 of 5 pages

     

    Item 6.

    Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

    Item 6 to the Schedule 13D is hereby amended and supplemented as follows:

    Item 4 above summarizes certain provisions of the Share Repurchase Agreement and is incorporated herein by reference. A copy of such agreement is attached as an exhibit to this Schedule 13D and is incorporated herein by reference.

    Except as set forth herein, the Reporting Persons do not have any contracts, arrangements, understandings or relationships (legal or otherwise) with any person with respect to any securities of the Issuer, including but not limited to any contracts, arrangements, understandings or relationships concerning the transfer or voting of such securities, finder’s fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or losses, or the giving or withholding of proxies.

     

    Item 7.

    Materials to be Filed as Exhibits.

    Item 7 to the Schedule 13D is hereby amended and supplemented as follows:

     

    Exhibit
    Number
      

    Description

    3    Share Repurchase Agreement, dated as of December 8, 2023.


    CUSIP No. 0076CA104    13D    Page 5 of 5 pages

     

    SIGNATURES

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: December 20, 2023

     

    Vereniging AEGON
    By:   /s/ L.J. Hijmans van den Bergh
    Name: L.J. Hijmans van den Bergh
    Title: Chairman
    Get the next $AEG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AEG

    DatePrice TargetRatingAnalyst
    5/7/2025Neutral → Outperform
    BNP Paribas Exane
    10/22/2024Neutral → Buy
    UBS
    5/28/2024Buy → Neutral
    UBS
    6/9/2023Hold → Buy
    HSBC Securities
    4/4/2023Neutral
    BofA Securities
    9/13/2022Hold → Buy
    Societe Generale
    7/5/2022Neutral → Underperform
    Exane BNP Paribas
    1/19/2022Underperform → Neutral
    BofA Securities
    More analyst ratings

    $AEG
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AM Best Affirms Credit Ratings of Members of Aegon Ltd.'s U.S. Subsidiaries

      AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Ratings of "a+" (Excellent) of the U.S. life/health (L/H) subsidiaries of Aegon Ltd. (Bermuda) (NYSE:AEG). Aegon Ltd.'s U.S. L/H companies are Transamerica Life Insurance Company (Cedar Rapids, IA) and Transamerica Financial Life Insurance Company (Harrison, NY) and referred to collectively as Aegon USA Group (Aegon USA). The outlook of these Credit Ratings (ratings) is stable. The ratings reflect Aegon USA's balance sheet strength, which AM Best assesses as very strong, as well as its strong operating performance, favorable business profile and appropriate enterprise risk management. AM

      1/28/25 5:31:00 PM ET
      $AEG
      Life Insurance
      Finance
    • Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on Aegon Ltd. (NYSE: AEG, Euronext: AGN)

      NOTE TO EDITORS: The Following is an Investment Opinion Issued by Spruce Point Capital Management Illustrates Why We Believe World Financial Group Operates an Aggressive Multi-Level-Marketing Business but Has Faced Allegations of Being a Pyramid Scheme Provides Evidence of FTC "Warning Signs" Such as Aggressive Claims in Their Recruiting and Sales Tactics Questions Management's Choice to Rely on Indexed-Universal Life Insurance Sales for Growth Expresses Concerns Over an Upstart Competitor Founded by One of World Financial Group's Former Top Producing Agents and the Impact It Could Have On World Financial Group's Recruiting Goals Estimates That a Sum-of-Parts Illustrative Valuatio

      12/16/24 7:30:00 AM ET
      $AEG
      Life Insurance
      Finance
    • AM Best Affirms Credit Ratings of Members of Aegon Ltd.'s U.S. Subsidiaries

      AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Ratings of "a+" (Excellent) of the U.S. life/health (L/H) subsidiaries of Aegon Ltd. (Bermuda) (NYSE:AEG). Aegon Ltd.'s U.S. L/H companies are Transamerica Life Insurance Company (Cedar Rapids, IA) and Transamerica Financial Life Insurance Company (Harrison, NY) and referred to collectively as Aegon USA Group (Aegon USA). The outlook of these Credit Ratings (ratings) is stable. The ratings reflect Aegon USA's balance sheet strength, which AM Best assesses as very strong, as well as its strong operating performance, favorable business profile and appropriate enterprise risk management. Aeg

      12/20/23 2:29:00 PM ET
      $AEG
      Life Insurance
      Finance

    $AEG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Aegon Ltd. New York Registry Shares (Amendment)

      SC 13G/A - AEGON LTD. (0000769218) (Subject)

      2/9/24 12:59:27 PM ET
      $AEG
      Life Insurance
      Finance
    • SEC Form SC 13G/A filed by Aegon Ltd. New York Registry Shares (Amendment)

      SC 13G/A - AEGON LTD. (0000769218) (Subject)

      2/8/24 12:26:49 PM ET
      $AEG
      Life Insurance
      Finance
    • SEC Form SC 13D/A filed by Aegon Ltd. New York Registry Shares (Amendment)

      SC 13D/A - AEGON LTD. (0000769218) (Subject)

      12/29/23 6:43:57 AM ET
      $AEG
      Life Insurance
      Finance

    $AEG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Aegon N.V. upgraded by BNP Paribas Exane

      BNP Paribas Exane upgraded Aegon N.V. from Neutral to Outperform

      5/7/25 8:33:19 AM ET
      $AEG
      Life Insurance
      Finance
    • Aegon N.V. upgraded by UBS

      UBS upgraded Aegon N.V. from Neutral to Buy

      10/22/24 6:09:17 AM ET
      $AEG
      Life Insurance
      Finance
    • Aegon N.V. downgraded by UBS

      UBS downgraded Aegon N.V. from Buy to Neutral

      5/28/24 7:28:06 AM ET
      $AEG
      Life Insurance
      Finance

    $AEG
    Financials

    Live finance-specific insights

    See more
    • Aegon completes share buyback program

      Aegon has completed the share buyback program announced on September 17, 2021, aimed at neutralizing the dilutive effect of the 2021 interim dividend paid in shares. The repurchased shares will be held as treasury shares and will be used to pay future dividends in shares. Between October 1, 2021 and October 26, 2021 common shares for an amount of EUR 96 million were repurchased. A total of 21,531,927 common shares were repurchased at an average price of EUR 4.46 per share. For further details visit our share buyback updates page at aegon.com. About Aegon Aegon's roots go back more than 175 years – to the first half of the nineteenth century. Since then, Aegon has grown into an internati

      10/27/21 2:00:00 AM ET
      $AEG
      Life Insurance
      Finance
    • Aegon to repurchase shares to neutralize impact of 2021 interim dividend paid in shares

      Aegon announced today that it will repurchase common shares for an amount of EUR 96 million to neutralize the dilutive effect of its 2021 interim dividend paid in shares. These shares will be held as treasury shares and will be used to pay future dividends in shares. Shareholders were given the opportunity to choose between receiving the 2021 interim dividend of EUR 0.08 per common share in cash or in shares. 58% of shareholders elected to receive the interim dividend in shares. The repurchase will commence on October 1, 2021 and is expected to be completed on or before October 26, 2021. Aegon will engage a third party to execute the transactions on its behalf. The common shares will be r

      9/17/21 2:00:00 AM ET
      $AEG
      Life Insurance
      Finance
    • Aegon completes share buyback program

      Aegon has completed the share buyback program to neutralize the dilutive effect of the 2020 final dividend paid in shares and certain share-based variable compensation plans for senior management, as announced on July 7, 2021. The repurchased shares will be held as treasury shares and will either be used to cover future dividends to be paid in shares or will be allocated to the participants of share-based variable compensation plans. Between July 8, 2021 and August 20, 2021 a total of 35,933,035 common shares were repurchased, at an average price of EUR 3.7013 per share. For further details, visit our share buyback updates page on aegon.com. About Aegon Aegon's roots go back more than

      8/23/21 2:00:00 AM ET
      $AEG
      Life Insurance
      Finance

    $AEG
    SEC Filings

    See more
    • SEC Form 6-K filed by Aegon Ltd. New York Registry Shares

      6-K - AEGON LTD. (0000769218) (Filer)

      5/8/25 8:46:40 AM ET
      $AEG
      Life Insurance
      Finance
    • SEC Form 6-K filed by Aegon Ltd. New York Registry Shares

      6-K - AEGON LTD. (0000769218) (Filer)

      4/9/25 6:09:24 AM ET
      $AEG
      Life Insurance
      Finance
    • Amendment: SEC Form 20-F/A filed by Aegon Ltd. New York Registry Shares

      20-F/A - AEGON LTD. (0000769218) (Filer)

      4/1/25 7:14:19 AM ET
      $AEG
      Life Insurance
      Finance